Neighbourly Pharmacy Inc. (TSE:NBLY – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is C$20.93.
A number of equities research analysts have commented on NBLY shares. Desjardins decreased their price objective on shares of Neighbourly Pharmacy from C$20.00 to C$18.50 and set a “hold” rating on the stock in a report on Wednesday, February 14th. National Bankshares dropped their price objective on shares of Neighbourly Pharmacy from C$20.50 to C$18.50 and set a “tender” rating for the company in a research report on Monday, January 15th. Finally, TD Securities lowered Neighbourly Pharmacy from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from C$28.00 to C$18.50 in a research report on Wednesday, February 14th.
View Our Latest Report on NBLY
Insider Activity at Neighbourly Pharmacy
Neighbourly Pharmacy Price Performance
Shares of NBLY stock opened at C$18.60 on Friday. The stock’s fifty day moving average is C$18.45 and its 200-day moving average is C$17.50. The company has a debt-to-equity ratio of 58.29, a quick ratio of 0.75 and a current ratio of 1.14. Neighbourly Pharmacy has a 52 week low of C$12.05 and a 52 week high of C$23.00. The stock has a market capitalization of C$835.51 million, a PE ratio of -25.48 and a beta of 0.29.
Neighbourly Pharmacy Company Profile
Neighbourly Pharmacy Inc owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading.
See Also
- Five stocks we like better than Neighbourly Pharmacy
- What is the FTSE 100 index?
- MarketBeat Week in Review – 4/29 – 5/3
- The How and Why of Investing in Biotech Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Most active stocks: Dollar volume vs share volume
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Neighbourly Pharmacy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neighbourly Pharmacy and related companies with MarketBeat.com's FREE daily email newsletter.